This inventor holds 1 USPTO granted patent. Top assignee: Nycomed Imaging as. Active years: 2001.
Company Filing History:
Years Active: 2001
Title: Tudor Griffith: Innovator in Atherosclerosis Treatment
Introduction
Tudor Griffith is a notable inventor based in Cardiff, GB. He has made significant contributions to the field of medical treatments, particularly in the area of atherosclerosis. His innovative approach utilizes chelating agents to address this serious health condition.
Latest Patents
Griffith holds a patent for the "Use of chelating agents in the treatment of atherosclerotic conditions." This invention provides a method for using dipyridoxyl or aminopolycarboxylic acid-based chelating agents, metal chelates, and their salts in the manufacture of therapeutic agents. These agents are designed for the treatment or prophylaxis of atherosclerosis and related conditions in both humans and non-human animals. The preferred compounds in this method include specific formulas that enhance the effectiveness of the treatment.
Career Highlights
Tudor Griffith is associated with Nycomed Imaging, where he has been able to apply his innovative ideas in a professional setting. His work has contributed to advancements in medical treatments, particularly in the management of cardiovascular diseases.
Collaborations
Griffith has collaborated with notable colleagues such as Anders Olsson and Bo Zieden. These partnerships have likely enriched his research and development efforts, leading to more effective solutions in the medical field.
Conclusion
Tudor Griffith's work in the use of chelating agents for treating atherosclerosis showcases his innovative spirit and dedication to improving health outcomes. His contributions are valuable in the ongoing fight against cardiovascular diseases.